RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Aberdeen
A

Aberdeen portfolio

Aberdeen has 6 portfolio companies on record at Recent Funding, with 2 investments in the last 12 months.

Type: Investor.
Portfolio on Recent Funding: 6.
Deals, last 12 months: 2.
Capital in their rounds: $702M.
Latest deal: Third Arc Bio · Feb 4, 2026.
About this page

Its most recent investment on record is Third Arc Bio's $52M Series A round in February 2026, alongside Marshall Wace, Galapagos, Goldman Sachs Alternatives and 6 others. By category, its portfolio leans toward Health and bio (5) and Fintech (1). It has co-invested with Andreessen Horowitz, T. Rowe Price and Biotechnology Value Fund.

What Aberdeen invests in

How Aberdeen invests

StageDealsCapital in rounds
Series B+ 1 50%$650M
Series A 1 50%$52M
YearDealsCapital in rounds
2025 1 50%$650M
2026 1 50%$52M

Aberdeen portfolio companies

CompanyRound with AberdeenTotal raisedLatest raise
TThird Arc Bio
Health and bio
 Series A · $52M$217MFeb 4, 2026
Series A
FFNZ
Fintech
 Series B+ · $650M$2.55BNov 12, 2025
Series B+
EEngrail Therapeutics
Health and bio
 backer$221MMar 19, 2024
Series B+
AAlpha-9 Oncology
Health and bio
 backer$175MOct 23, 2024
Series B+
AArbor Biotechnologies
Health and bio
 backer$289MMar 18, 2025
Series B+
GGlycomine
Health and bio
 backer$195MMay 9, 2025
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 2 rounds on Recent Funding that name Aberdeen. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Aberdeen, which is a subset of its real portfolio. API: /api/v1/investors/aberdeen (get a free API key). More: the most active VC firms and new venture capital funds.